ZA838033B - Sustained release solid dosage forms having non-uniform distribution of active ingredient - Google Patents

Sustained release solid dosage forms having non-uniform distribution of active ingredient

Info

Publication number
ZA838033B
ZA838033B ZA838033A ZA838033A ZA838033B ZA 838033 B ZA838033 B ZA 838033B ZA 838033 A ZA838033 A ZA 838033A ZA 838033 A ZA838033 A ZA 838033A ZA 838033 B ZA838033 B ZA 838033B
Authority
ZA
South Africa
Prior art keywords
active ingredient
dosage forms
sustained release
uniform distribution
solid dosage
Prior art date
Application number
ZA838033A
Other languages
English (en)
Inventor
Michael A Zoglio
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA838033B publication Critical patent/ZA838033B/xx

Links

ZA838033A 1982-11-01 1983-10-27 Sustained release solid dosage forms having non-uniform distribution of active ingredient ZA838033B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43810082A 1982-11-01 1982-11-01

Publications (1)

Publication Number Publication Date
ZA838033B true ZA838033B (en) 1984-06-27

Family

ID=23739215

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA838033A ZA838033B (en) 1982-11-01 1983-10-27 Sustained release solid dosage forms having non-uniform distribution of active ingredient

Country Status (2)

Country Link
JP (1) JPS5995214A (ja)
ZA (1) ZA838033B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0667828B2 (ja) * 1985-10-09 1994-08-31 日研化学株式会社 バルプロ酸ナトリウムの持続性顆粒製剤
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
CA2464653C (en) * 2001-10-29 2011-10-18 Therics, Inc. System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing

Also Published As

Publication number Publication date
JPS5995214A (ja) 1984-06-01

Similar Documents

Publication Publication Date Title
DE3368011D1 (en) Sustained release solid dosage forms having non-uniform distribution of active ingredient
GB8403138D0 (en) Sustained release of active ingredient
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
EP0467488A3 (en) Composition for the controlled discharge of an active ingredient
GB8307960D0 (en) Sustained release therapeutic compositions
GB2120937B (en) Implant for sustained release of pharmaceutical agents
IL57796A0 (en) Pharmaceutical compositions having retarded release of the active substance
AU553010B2 (en) Device for active ingredient release
PT72904A (en) Device for the metered release of active ingredient
DE3571924D1 (en) Dosage units for controlled release of active material
IL68887A (en) Extended action controlled release compositions containing a pharmacologically active base and a salt thereof
IL104192A0 (en) Pharmaceutical dosage forms having prolonged release rate of active ingredient
DE3378523D1 (en) Pharmaceutical formulations
DE3368057D1 (en) Pharmaceutically active aminobenzopyrans
IL75490A0 (en) Controlled release pharmaceutical compositions containing solid dispersions of active agent
ZA832549B (en) Pharmaceutically active compounds
EP0094513A3 (en) Sustained-release body containing an active ingredient
IL74049A0 (en) Controlled release liquid dosage pharmaceutical formulations
ZA838033B (en) Sustained release solid dosage forms having non-uniform distribution of active ingredient
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
ZA836031B (en) Constant release rate solid dosage theophylline formulation
GB2131292B (en) Progestational pharmaceutical formulations
SG103391G (en) Pharmaceutical formulations with controlled release of the active substance
GB8332164D0 (en) Of 4949 physiologically active substance